KMTS Stock Price | Kestra Medical Technologies, Ltd. Common Stock P/E, Revenue, EPS, & Forecasts

Kestra Medical Technologies, Ltd. Common Stock • KMTS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Kestra Medical Technologies, Ltd. Common Stock

Ticker

KMTS

Trading on

NASDAQ

ISIN

BMG524411052

Industry

Medical Instruments & Supplies

Sector

Healthcare

CEO

Brian Webster

Headquarters

3933 Lake Washington Blvd NE, Kirkland, WA, United States, 98033

Employees

330

Website

https://kestramedical.com

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Metrics

BasicAdvanced

Market cap

$1.36B

P/E ratio

EPS

-$3.96

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-121M

Ex dividend date

Price & volume

Market cap

$1.36B

Average daily volume

0.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

18.29

Price to book

8.29

Earnings

EPS

-$3.96

EPS estimate (current quarter)

-$0.53

EPS estimate (next quarter)

$0.00

EBITDA

$-121M

Revenues (TTM)

$74.3M

Revenues per share (TTM)

$1.84

Technicals

Beta

52-week High

$30.00

52-week Low

$13.25

50-day moving average

$25.57

200-day moving average

$22.19

Short ratio

9.83

Short %

7.86%

Management effectiveness

ROE (TTM)

-126.40%

ROA (TTM)

-43.95%

Profit margin

-177.99%

Gross profit margin

$34.5M

Operating margin

-140.73%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

53.40%

Share stats

Outstanding Shares

58.3M

Float

32.7M

Insiders %

5.13%

Institutions %

98.19%

Analyst Insights & forecasts

84% Buy

16% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$29.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.18

-$0.64

-84.38%

Q1 • 25Missed

-$1.06

-$0.53

-99.91%

Q2 • 25Missed

-$0.50

-$0.78

35.57%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$19.4M

$-25.8M

-133.32%

Q3 • 25

$22.6M

$-32.8M

-145.29%

Q4 • 25

16.49%

26.95%

8.98%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$266M

$82.1M

30.84%

Q3 • 25

$247M

$82.6M

33.49%

Q4 • 25

-7.36%

0.59%

8.58%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-26.3M

$-8.2M

$-1.9M

$-34.4M

Q3 • 25

$-18.3M

$-0M

$-25.6M

Q4 • 25

-30.19%

-98.56%

-25.64%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Kestra Medical Technologies, Ltd. Common Stock share?

Kestra Medical Technologies, Ltd. Common Stock shares are currently traded for undefined per share.

How many shares does Kestra Medical Technologies, Ltd. Common Stock have?

Kestra Medical Technologies, Ltd. Common Stock currently has 58.3M shares.

Does Kestra Medical Technologies, Ltd. Common Stock pay dividends?

No, Kestra Medical Technologies, Ltd. Common Stock doesn't pay dividends.

What is Kestra Medical Technologies, Ltd. Common Stock 52 week high?

Kestra Medical Technologies, Ltd. Common Stock 52 week high is $30.00.

What is Kestra Medical Technologies, Ltd. Common Stock 52 week low?

Kestra Medical Technologies, Ltd. Common Stock 52 week low is $13.25.

What is the 200-day moving average of Kestra Medical Technologies, Ltd. Common Stock?

Kestra Medical Technologies, Ltd. Common Stock 200-day moving average is $22.19.

Who is Kestra Medical Technologies, Ltd. Common Stock CEO?

The CEO of Kestra Medical Technologies, Ltd. Common Stock is Brian Webster.

How many employees Kestra Medical Technologies, Ltd. Common Stock has?

Kestra Medical Technologies, Ltd. Common Stock has 330 employees.

What is the market cap of Kestra Medical Technologies, Ltd. Common Stock?

The market cap of Kestra Medical Technologies, Ltd. Common Stock is $1.36B.

What is the P/E of Kestra Medical Technologies, Ltd. Common Stock?

The current P/E of Kestra Medical Technologies, Ltd. Common Stock is null.

What is the EPS of Kestra Medical Technologies, Ltd. Common Stock?

The EPS of Kestra Medical Technologies, Ltd. Common Stock is -$3.96.

What is the PEG Ratio of Kestra Medical Technologies, Ltd. Common Stock?

The PEG Ratio of Kestra Medical Technologies, Ltd. Common Stock is null.

What do analysts say about Kestra Medical Technologies, Ltd. Common Stock?

According to the analysts Kestra Medical Technologies, Ltd. Common Stock is considered a buy.